Dr. James Abbott, MD

Dr. Abbott practices at St. Luke's Wood River Medical Center in Ketchum, Idaho, part of St. Luke's Health System.

Dr. Abbott's NPI, 1518490283, was assigned on April 9, 2017. Dr. Abbott graduated from Drexel University College of Medicine in 2017. Dr. Abbott holds Montana license MED-PHYS-LIC-109898.

Dr. Abbott's primary practice is St. Luke's Wood River Medical Center, at 100 Hospital Drive, Ketchum, ID 83340 in Blaine County. The practice phone is (208) 727-8800.

Dr. Abbott's primary practice is St. Luke's Wood River Medical Center in Ketchum, Idaho, part of St. Luke's Health System. Dr. Abbott is also affiliated with Billings Clinic Hospital. The medical group on file is St. Luke’s Clinic, Internal Medicine: Ketchum. Dmand AI also links Dr. Abbott to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abbott practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Abbott's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Abbott's licenses on file in 2 states: Montana and Utah.

CMS data shows 6,806 Medicare services from Dr. Abbott across 27 procedure codes in 2024, for 1,992 Medicare patients. Medicare paid $151,268 for them.

CMS counts 1,992 Medicare patients who saw Dr. Abbott in 2024. The largest group is 65 to 74, with 913 patients. 64% of them have high blood pressure, and 56% have high cholesterol. 6% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abbott's median patient age at 74, with 49% women.

In 2024, Dr. Abbott wrote 613 Medicare Part D claims for 247 patients. 82% of them were for generic drugs. CMS names the drug for 483 of them, across 15 drugs with 11 or more claims each, at $868,643 in total drug cost. In 2023, CMS named 143 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Abbott for performance year 2024, reported through an alternative payment model (APM). Dr. Abbott accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 460 procedures of skin biopsy by Dr. Abbott, more than 95% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 38 papers to Dr. Abbott, published from 2015 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Skin Neoplasms, Melanoma and Nails. Dr. Abbott has published most often in Am J Dermatopathol. Dr. Abbott's most frequent co-authors are Rosalie Elenitsas, MD, Emily Y. Chu, MD and Scott R. Florell, MD.

CMS Open Payments shows 5 general payments to Dr. Abbott from 2 drug and device companies from 2020 to 2023. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $313.

Dr. Abbott graduated from Drexel University College of Medicine in 2017.